New \'smart drug\' shows promise for metastatic triplenegative breast cancer

New 'smart drug' shows promise for metastatic triple-negative breast cancer

A new "smart drug" has shown promise for women with metastatic triple-negative breast cancer, based on data from a clinical trial published in the New England Journal of Medicine.  "I think this drug has the potential to change practice, because the...

More From BioPortfolio on "New 'smart drug' shows promise for metastatic triple-negative breast cancer"